FindTrial
Sign In

Evaluation of endoscopic sentinel lymph node biopsy in breast conserving surgery for breast cancer

Evaluation of endoscopic sentinel lymph node biopsy in breast conserving surgery for breast cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043403
Enrollment
Unknown
Registered
2021-02-14
Start date
2021-02-14
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Endoscopic Group:Endoscopic Sentinel Lymph Node Biopsy
Open Group:Open Sentinel Lymph Node Biopsy

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-70 years, female; 2. Biopsy confirmed invasive breast cancer; 3. Complying with NCCN guidelines for breast-conserving surgery and sentinel lymph node surgery; 4. Requiring breast-conserving and sentinel biopsy; 5. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous axillary surgery; 2. Unable or refusing postoperative radiotherapy; 3. Patients with mental illness or other reasons for not complying with treatment; 4. Unable to complete the questionnaire.

Design outcomes

Primary

MeasureTime frame
Sentinel lymph node detection rate;Number of sentinel lymph nodes detected;Sentinel lymph node positive rate;Overall survival;Local recurrence rate;Postoperative complications;—

Secondary

MeasureTime frame
Breast-Q Score;AIS Score;The arm circumference;—

Countries

China

Contacts

Public ContactChen Jie

West China Hospital, Sichuan University

chenjiedoctor@126.com+86 189 8060 6313

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026